SLC6A2 genotype variation and the modulatory effects of atomoxetine on inhibitory control in individuals with and without cocaine use disorder (2017)
Attributed to:
Atomoxetine as a pharmacological treatment for chronic cocaine and heroin abusers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0924-977x(17)31865-5
Publication URI: http://dx.doi.org/10.1016/s0924-977x(17)31865-5
Type: Journal Article/Review
Parent Publication: European Neuropsychopharmacology